September 30, 2020
This content is from:
The long-short fund has heavily benefitted this year from several venture capital deals.
May 10, 2021
The little known life sciences hedge fund firm is a major investor in Covid-19 vaccine developer Novavax.
April 27, 2021
Several hedge funds, including Baupost Group, participated in the recent private placement of clinical-stage biopharma company Translate Bio.
May 31, 2019
Tiger Global, Cormorant Capital, and Perceptive Advisors are among the investors expected to benefit from upcoming IPOs.
April 19, 2021